CLOV vs SRNE
Clover Health Investments Corp (CLOV) versus Sorrento Therape (SRNE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
SRNE does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. SRNE currently screens at market cap $385.9K.
Not investment advice. Open the CLOV and SRNE stock pages for the full models.
Not investment advice.